378 related articles for article (PubMed ID: 15837926)
1. Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase.
Davis MI; Bennett MJ; Thomas LM; Bjorkman PJ
Proc Natl Acad Sci U S A; 2005 Apr; 102(17):5981-6. PubMed ID: 15837926
[TBL] [Abstract][Full Text] [Related]
2. Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity.
Barinka C; Sácha P; Sklenár J; Man P; Bezouska K; Slusher BS; Konvalinka J
Protein Sci; 2004 Jun; 13(6):1627-35. PubMed ID: 15152093
[TBL] [Abstract][Full Text] [Related]
3. Mapping of the active site of glutamate carboxypeptidase II by site-directed mutagenesis.
Mlcochová P; Plechanovová A; Barinka C; Mahadevan D; Saldanha JW; Rulísek L; Konvalinka J
FEBS J; 2007 Sep; 274(18):4731-41. PubMed ID: 17714508
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs.
Barinka C; Hlouchova K; Rovenska M; Majer P; Dauter M; Hin N; Ko YS; Tsukamoto T; Slusher BS; Konvalinka J; Lubkowski J
J Mol Biol; 2008 Mar; 376(5):1438-50. PubMed ID: 18234225
[TBL] [Abstract][Full Text] [Related]
5. Cloning and characterization of canine prostate-specific membrane antigen.
Schmidt S; Fracasso G; Colombatti M; Naim HY
Prostate; 2013 May; 73(6):642-50. PubMed ID: 23359458
[TBL] [Abstract][Full Text] [Related]
6. Comparison of human glutamate carboxypeptidases II and III reveals their divergent substrate specificities.
Navrátil M; Tykvart J; Schimer J; Pachl P; Navrátil V; Rokob TA; Hlouchová K; Rulíšek L; Konvalinka J
FEBS J; 2016 Jul; 283(13):2528-45. PubMed ID: 27208881
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of prostate-specific membrane antigen recognition by the A9g RNA aptamer.
Ptacek J; Zhang D; Qiu L; Kruspe S; Motlova L; Kolenko P; Novakova Z; Shubham S; Havlinova B; Baranova P; Chen SJ; Zou X; Giangrande P; Barinka C
Nucleic Acids Res; 2020 Nov; 48(19):11130-11145. PubMed ID: 32525981
[TBL] [Abstract][Full Text] [Related]
8. Recombinant glutamate carboxypeptidase II (prostate specific membrane antigen--PSMA)--cellular localization and bioactivity analyses.
Meighan MA; Dickerson MT; Glinskii O; Glinsky VV; Wright GL; Deutscher SL
J Protein Chem; 2003 May; 22(4):317-26. PubMed ID: 13678295
[TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization of human glutamate carboxypeptidase III.
Hlouchová K; Barinka C; Klusák V; Sácha P; Mlcochová P; Majer P; Rulísek L; Konvalinka J
J Neurochem; 2007 May; 101(3):682-96. PubMed ID: 17241121
[TBL] [Abstract][Full Text] [Related]
10. Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer.
Mesters JR; Barinka C; Li W; Tsukamoto T; Majer P; Slusher BS; Konvalinka J; Hilgenfeld R
EMBO J; 2006 Mar; 25(6):1375-84. PubMed ID: 16467855
[TBL] [Abstract][Full Text] [Related]
11. Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA).
Mhaka A; Gady AM; Rosen DM; Lo KM; Gillies SD; Denmeade SR
Cancer Biol Ther; 2004 Jun; 3(6):551-8. PubMed ID: 15044850
[TBL] [Abstract][Full Text] [Related]
12. Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA).
Barinka C; Ptacek J; Richter A; Novakova Z; Morath V; Skerra A
Protein Eng Des Sel; 2016 Mar; 29(3):105-15. PubMed ID: 26802163
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptide.
Conway RE; Rojas C; Alt J; Nováková Z; Richardson SM; Rodrick TC; Fuentes JL; Richardson NH; Attalla J; Stewart S; Fahmy B; Barinka C; Ghosh M; Shapiro LH; Slusher BS
Angiogenesis; 2016 Oct; 19(4):487-500. PubMed ID: 27387982
[TBL] [Abstract][Full Text] [Related]
14. Structural insight into the evolutionary and pharmacologic homology of glutamate carboxypeptidases II and III.
Hlouchova K; Barinka C; Konvalinka J; Lubkowski J
FEBS J; 2009 Aug; 276(16):4448-62. PubMed ID: 19678840
[TBL] [Abstract][Full Text] [Related]
15. Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells.
Bakht MK; Hayward JJ; Shahbazi-Raz F; Skubal M; Tamura R; Stringer KF; Meister D; Venkadakrishnan VB; Xue H; Pillon A; Stover M; Tronchin A; Fifield BA; Mader L; Ku SY; Cheon GJ; Kang KW; Wang Y; Dong X; Beltran H; Grimm J; Porter LA; Trant JF
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35064078
[TBL] [Abstract][Full Text] [Related]
16. Disulfide-constrained peptides that bind to the extracellular portion of the prostate-specific membrane antigen.
Lupold SE; Rodriguez R
Mol Cancer Ther; 2004 May; 3(5):597-603. PubMed ID: 15141017
[TBL] [Abstract][Full Text] [Related]
17. Potential effective inhibitory compounds against Prostate Specific Membrane Antigen (PSMA): A molecular docking and molecular dynamics study.
Nikfarjam Z; Bavi O; Amini SK
Arch Biochem Biophys; 2021 Mar; 699():108747. PubMed ID: 33422503
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA.
Ivanenkov YA; Machulkin AE; Garanina AS; Skvortsov DA; Uspenskaya AA; Deyneka EV; Trofimenko AV; Beloglazkina EK; Zyk NV; Koteliansky VE; Bezrukov DS; Aladinskaya AV; Vorobyeva NS; Puchinina MM; Riabykh GK; Sofronova AA; Malyshev AS; Majouga AG
Bioorg Med Chem Lett; 2019 May; 29(10):1246-1255. PubMed ID: 30904185
[TBL] [Abstract][Full Text] [Related]
19. Amino acids at the N- and C-termini of human glutamate carboxypeptidase II are required for enzymatic activity and proper folding.
Barinka C; Mlcochová P; Sácha P; Hilgert I; Majer P; Slusher BS; Horejsí V; Konvalinka J
Eur J Biochem; 2004 Jul; 271(13):2782-90. PubMed ID: 15206943
[TBL] [Abstract][Full Text] [Related]
20. Is prostate-specific membrane antigen a multifunctional protein?
Rajasekaran AK; Anilkumar G; Christiansen JJ
Am J Physiol Cell Physiol; 2005 May; 288(5):C975-81. PubMed ID: 15840561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
